BIOMAT Database Logo BIOMAT Database Logo

Effect of nitrazepam, amylobarbitone sodium and placebo on the electroencephalogram of normal subjects. 1969

J V Volavka, and C R Joyce, and M J Maloney, and W Brawn, and J Summerfield, and C Topham, and D F Scott

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D008297 Male Males
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000654 Amobarbital A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565) Amylobarbitone,Pentymal,Amobarbital Sodium,Amsal,Amylbarb sodium,Amylobeta,Amytal,Amytal Sodium,Barbamyl,Eunoctal,Isoamitil Sedante,Isonal,Neur-Amyl,Novamobarb,Placidel,Sodium Amobarbital,Sodium Amytal,Transital,Amobarbital, Sodium,Sodium, Amobarbital
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.

Related Publications

J V Volavka, and C R Joyce, and M J Maloney, and W Brawn, and J Summerfield, and C Topham, and D F Scott
Effects of nitrazepam, amylobarbitone and placebo on some perceptual, motor and cognitive tasks in normal subjects.
January 1969, Psychopharmacologia,
J V Volavka, and C R Joyce, and M J Maloney, and W Brawn, and J Summerfield, and C Topham, and D F Scott
Subjective and objective effects of nitrazepam and amylobarbitone sodium in normal human beings.
January 1972, Psychopharmacologia,
J V Volavka, and C R Joyce, and M J Maloney, and W Brawn, and J Summerfield, and C Topham, and D F Scott
Evaulation of the effect of fosazepam (a new benzodiazepine), nitrazepam and placebo on sleep patterns in normal subjects.
October 1977, European journal of clinical pharmacology,
J V Volavka, and C R Joyce, and M J Maloney, and W Brawn, and J Summerfield, and C Topham, and D F Scott
Behaviour and EEG are affected on the day after hypnotic doses of nitrazepam and amylobarbitone sodium.
October 1969, British journal of pharmacology,
J V Volavka, and C R Joyce, and M J Maloney, and W Brawn, and J Summerfield, and C Topham, and D F Scott
Persistent behavioural and electroencephalographic changes after single doses of nitrazepam and amylobarbitone sodium.
June 1970, British medical journal,
J V Volavka, and C R Joyce, and M J Maloney, and W Brawn, and J Summerfield, and C Topham, and D F Scott
A controlled comparison of nitrazepam ('mogadon') with sodium amylobarbitone as a sleep-inducing agent.
September 1967, The British journal of psychiatry : the journal of mental science,
J V Volavka, and C R Joyce, and M J Maloney, and W Brawn, and J Summerfield, and C Topham, and D F Scott
Effects of amylobarbitone and nitrazepam on the electrodermogram and other features of sleep.
May 1971, The British journal of psychiatry : the journal of mental science,
J V Volavka, and C R Joyce, and M J Maloney, and W Brawn, and J Summerfield, and C Topham, and D F Scott
Persistent electroencephalographic and behavioural changes following nitrazepam and amylobarbitone.
July 1970, Electroencephalography and clinical neurophysiology,
J V Volavka, and C R Joyce, and M J Maloney, and W Brawn, and J Summerfield, and C Topham, and D F Scott
The effect of age on the hydroxylation of amylobarbitone sodium in man.
February 1974, British journal of clinical pharmacology,
J V Volavka, and C R Joyce, and M J Maloney, and W Brawn, and J Summerfield, and C Topham, and D F Scott
A repeated dose comparison of dichloralphenazone, flunitrazepam and amylobarbitone sodium on some aspects of sleep and early morning behaviour in normal subjects.
April 1977, British journal of clinical pharmacology,
Copied contents to your clipboard!